ZHOU, S.; DENG, M.; BIAN, X.; SHI, J.; LIANG, R.; TAO, M. Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma: Role of ADRB2 and mTOR/PI3K/AKT in LUAD. Cellular and Molecular Biology, [S. l.], v. 70, n. 2, p. 120–127, 2024. DOI: 10.14715/cmb/2024.70.2.17. Disponível em: https://www.cellmolbiol.org/index.php/CMB/article/view/5253. Acesso em: 20 may. 2024.